SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-11-002087
Filing Date
2011-09-16
Accepted
2011-09-16 11:42:45
Documents
1
Period of Report
2011-08-02

Document Format Files

Seq Description Document Type Size
1 q11-00716.html 3  
1 q11-00716.xml 3 5650
  Complete submission text file 0001387131-11-002087.txt   7099
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11455 EL CAMINO REAL, SUITE 310 SAN DIEGO CA 92130
Business Address
Daniels Karen K. (Reporting) CIK: 0001530197 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26372 | Film No.: 111094308